2-((4-(4-Bromophenyl)-5-(pyridin-3-yl)-4H-1,2,4-triazol-3-yl)thio)-N-(3-chloro-2-methylphenyl)acetamide

Catalog No. :
ACIMXR216
CAS No. :
477329-87-6
Molecular Formula :
C22H17BrClN5OS
Molecular Weight :
514.84

IUPAC Name:2-((4-(4-bromophenyl)-5-(pyridin-3-yl)-4H-1,2,4-triazol-3-yl)thio)-N-(3-chloro-2-methylphenyl)acetamide

2-((4-(4-Bromophenyl)-5-(pyridin-3-yl)-4H-1,2,4-triazol-3-yl)thio)-N-(3-chloro-2-methylphenyl)acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-((4-(4-Bromophenyl)-5-(pyridin-3-yl)-4H-1,2,4-triazol-3-yl)thio)-N-(3-chloro-2-methylphenyl)acetamide
IUPAC Name2-((4-(4-bromophenyl)-5-(pyridin-3-yl)-4H-1,2,4-triazol-3-yl)thio)-N-(3-chloro-2-methylphenyl)acetamide
Molecular FormulaC22H17BrClN5OS
Molecular Weight514.84
SMILESO=C(NC1=CC=CC(Cl)=C1C)CSC2=NN=C(C3=CC=CN=C3)N2C4=CC=C(Br)C=C4
InChI KeyKFQGCRZFQWIMQZ-UHFFFAOYSA-N
SynonymSALOR-INT L243396-1EA;2-([4-(4-BROMOPHENYL)-5-(3-PYRIDINYL)-4H-1,2,4-TRIAZOL-3-YL]SULFANYL)-N-(3-CHLORO-2-METHYLPHENYL)ACETAMIDE;Acetamide, 2-[[4-(4-bromophenyl)-5-(3-pyridinyl)-4H-1,2,4-triazol-3-yl]thio]-N-(3-chloro-2-methylphenyl)-
CAS No.477329-87-6

Synthetic Route by SureRoute

1. ACIMXR216 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBTWK016 route compound structure diagram
    ACBTWK01687-60-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIMXR216 route product structure diagram
    ACIMXR216477329-87-6
Inquiry

2. ACIMXR216 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACZAEU048 route compound structure diagram
    ACZAEU04899585-94-1
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIMXR216 route product structure diagram
    ACIMXR216477329-87-6
Inquiry

Comments (0)